HCV screening of pregnant and nonpregnant women in the US are increasing but remain suboptimal suggesting the need for ...
Hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic ...
Hepatitis B and C still survive in the dark, driven by a lack of information, unhygienic medical procedures, and poor access ...
Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a ...
The Rotary Club of Buckhannon-Upshur and WVU Medicine St. Joseph’s Hospital will hold blood screenings on Saturdays on April ...
Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...
University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...
Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...
Incident HCV infection more than doubled among HIV-positive MSM with no history of injection drug use between 1995 and 2023.
New South Wales Health has issued an urgent alert to 223 women who may have been exposed to low-risk hepatitis B while giving ...
Viral hepatitis is an inflammatory disease of the ... the authors functionally and structurally characterize broadly neutralizing antibodies isolated from HEV convalescent individuals and show ...
Hepatitis E, tetanus and hepatitis B all pose significant but under-reported threats to the health and lives of women and girls, especially in low-income countries with limited access to healthcare.